News

Filter

Current filters:

AbbVieUSA

1 to 9 of 44 results

US FDA warns on over-prescribing of testosterone products

US FDA warns on over-prescribing of testosterone products

04-03-2015

The US Food and Drug Administration is requiring that the manufacturers of all approved prescription…

AbbVieAndroGelAxironEli LillyMen's HealthPharmaceuticalRegulationUSA

US FDA approves AbbVie’s Duopa for Parkinson’s disease

US FDA approves AbbVie’s Duopa for Parkinson’s disease

13-01-2015

The US Food and Drug Administration has approved US drugmaker AbbVie’s Duopa (carbidopa and levodopa)…

AbbVieCarbidopa-LevodopaNeurologicalPharmaceuticalRegulationUSA

AbbVie issues earnings-per-share guidance up 30% for 2015

AbbVie issues earnings-per-share guidance up 30% for 2015

12-01-2015

US drugmaker AbbVie has issued updated guidance about its expected earnings in 2015.

AbbVieAnti-viralsFinancialHumiraPharmaceuticalUSAViekira Pak

Tenfold growth by 2023 forecast for celiac disease drug market

Tenfold growth by 2023 forecast for celiac disease drug market

08-01-2015

The celiac disease treatment market value will expand more than tenfold from an estimated $49.6 million…

AbbVieEuropeGastro-intestinalslarazotide acetatelatiglutenaseMarkets & MarketingPharmaceuticalTeva Pharmaceutcal IndustriesUSA

Express Scripts says AbbVie’s Viekira Pak to be exclusive option for genotype 1 hepatitis C

Express Scripts says AbbVie’s Viekira Pak to be exclusive option for genotype 1 hepatitis C

22-12-2014

Express Scripts today announced an update to its National Preferred Formulary that will significantly…

AbbVieAnti-viralsExpress ScriptsGilead SciencesHarvoniPharmaceuticalPricingSovaldiUSAViekira Pak

FDA approves fourth hepatitis C drug, AbbVie’s Viekira Pak

FDA approves fourth hepatitis C drug, AbbVie’s Viekira Pak

20-12-2014

The US Food and Drug Administration on Friday confirmed the much anticipated approval of US pharma company…

AbbVieAnti-viralsPharmaceuticalRegulationUSAViekira Pak

ASH 2014: AbbVie's venetoclax shows promise in Phase II trial

ASH 2014: AbbVie's venetoclax shows promise in Phase II trial

08-12-2014

US drugmaker AbbVie presented data at the American Society of Hematology’s annual meeting, demonstrating…

AbbVieOncologyPharmaceuticalResearchUSA

AbbVie signs agreement with Medicines Patent Pool for lopinavir and retonavir in pediatric HIV

AbbVie signs agreement with Medicines Patent Pool for lopinavir and retonavir in pediatric HIV

01-12-2014

US drugmaker AbbVie and the Medicines Patent Pool have agreed a licensing agreement for lopinavir and…

AbbVieAnti-viralsLopinavirPharmaceuticalResearchRitonavir TabletsUSA

1 to 9 of 44 results

Back to top